iodoazomycin arabinoside has been researched along with Experimental Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McEwan, AJ; Mercer, JR; Wiebe, LI | 1 |
| Chapman, JD; Coia, LR; Engelhardt, EL; Fenning, MC; Schneider, RF; Stobbe, CC | 1 |
| Kumar, P; Lee, HC; McEwan, AJ; Mercer, JR; Wiebe, LI | 1 |
| Chapman, JD; Lee, J; Mannan, RH; Mercer, JR; Somayaji, VV; Wiebe, LI | 1 |
4 other study(ies) available for iodoazomycin arabinoside and Experimental Neoplasms
| Article | Year |
|---|---|
[131I]IAZA as a molecular radiotherapeutic (MRT) drug: wash-out with cold IAZA accelerates clearance in a murine tumor model.
Topics: Animals; Cold Temperature; Healthy Volunteers; Humans; Iodine Radioisotopes; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Nitroimidazoles; Radiopharmaceuticals; Tissue Distribution | 2013 |
Prediction of tumour hypoxia and radioresistance with nuclear medicine markers.
Topics: Animals; Cell Hypoxia; Mice; Mice, SCID; Neoplasms, Experimental; Nitroimidazoles; Radiation Tolerance; Rats; Tomography, Emission-Computed, Single-Photon | 1996 |
Synthesis, radiolabeling, and biodistribution of putative metabolites of iodoazomycin arabinoside.
Topics: Animals; Injections, Intravenous; Iodine Radioisotopes; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Nitroimidazoles; Radionuclide Imaging; Tissue Distribution | 2000 |
Radioiodinated 1-(5-iodo-5-deoxy-beta-D-arabinofuranosyl)-2-nitroimidazole (iodoazomycin arabinoside: IAZA): a novel marker of tissue hypoxia.
Topics: Animals; Cell Hypoxia; Iodine Radioisotopes; Male; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Tissue Distribution | 1991 |